Casdin Capital — Full Portfolio

Century Therapeutics develops allogeneic, iPSC-derived cell therapies using gene editing and protein engineering for autoimmune diseases including type 1 diabetes and cancer.

AI & Machine LearningBiotechHealthtechMedical DevicesPhiladelphia, US

Osvaldo Flores, Ph.D.(Executive Officer, Director)Douglas Carr(Executive Officer)inBPBrent Pfeiffenberger(President and Chief Executive Officer)inGregory Russotti(Chief Technology and Manufacturing Officer)CCChad Cowan(Chief Scientific Officer)in

BoardToshikazu Ban(Director)

Board seatECEli Casdin· per SEC Form D

Co-investorsLILifeSci Venture PartnersRARA CapitalVEVersant Ventures

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.

BiotechHealthtechEmeryville, US

DKDavid Kirn(Executive Officer, Director)inDSDavid Schaffer(Director)inTheresa Janke(Executive Officer)in

BoardSharon Tetlow(Director)Margi McLoughlin(Director)

Co-investorsAMAmzak HealthBEBerkeley CatalystBOBOLD LongevityCHChiesi VenturesPAPappas CapitalPFPfizer Venture Investments+7 more

908 Devices manufactures handheld mass spectrometry and chemical analysis devices for rapid detection in defense, security, and hazardous materials response applications.

Deep TechDefense TechHardwareMedical DevicesBoston, US

KJKevin J. Knopp, PhD(CEO & Co-founder)CBChristopher Brown(Executive Officer)inKKKevin Knopp(Executive Officer, Director)inJoseph Griffith IV(Executive Officer)

BoardKHKevin Hrusovsky(Director)Corey Steffek(Director)

Co-investorsARARCH Venture PartnersINIn-Q-TelRARazor's Edge VenturesUTUTECARAramco VenturesARARK Investment Management+4 more

Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSeattle, US

CRChad Robins(Chief Executive Officer, Co-founder, Chairman of the Board)inHRHarlan Robins(Co-founder; Chief Scientific Officer until 2026)inKDKathleen Determann(Executive Officer)inDean Schorno(Executive Officer)inChris Carlson(Executive Officer)KPKyle Piskel(Chief Financial Officer)in

Co-investorsDEDecheng CapitalFMFMG CapitalFOForesite CapitalKHKhosla VenturesVIViking GlobalOROrbiMed

Contineum is a biopharmaceutical company developing small molecule drug candidates to treat inflammatory and fibrotic diseases by modulating critical disease pathways.

BiotechHealthtech

CSCarmine Stengone(President and Chief Executive Officer)inPTPeter T. Slover(Chief Financial Officer)inDSDaniel S. Lorrain(Chief Scientific Officer)inTimothy R. Watkins(Chief Medical Officer and Head of Development)in

Co-investorsHAHadean VenturesRERed Tree VentureSASamsara BioCapitalFRFranklin TempletonJJJJDCSESectoral Asset Management+1 more

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

JKJason Kelly(Founder)inRSReshma Shetty(Founder)inBCBarry Canton(Founder)inACAustin Che(Founder)inTKTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors1111.2 CapitalALAllen Institute for AI (AI2) IncubatorAZAzure Capital PartnersB3B3 HoldingBLBlue Owl CapitalCACannage Capital+62 more

Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.

AI & Machine LearningBiotechSouth San Francisco, US

CHCharles Homcy(Director)JCJason Coloma(Chief Executive Officer)in

Co-investorsANAndreessen HorowitzARARCH Venture PartnersFOForesite CapitalFRFrazier Life SciencesGVGV (Google Ventures)HEHercules Capital, Inc.+9 more

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

MWMarkus Warmuth(M.D., Chief Executive Officer)inSTSharon Townson(Ph.D., Chief Scientific Officer)inJCJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPNPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMWMagnus Walter(DPhil, Chief Technology Officer)in

Co-investorsAIAisling CapitalHBHBM PartnersNENew Enterprise Associates (NEA)VEVersant VenturesAMAmzak HealthAVAvoro Capital Advisors+4 more

Neurogene develops gene therapy treatments for rare neurological diseases.

BiotechDeep TechDigital HealthLongevityMedical DevicesNew York, US

RMRachel McMinn(Founder and Chief Executive Officer)inRMRachel McMinn, Ph.D.(Founder and Chief Executive Officer)

BoardCory Freedland(Director)inStephen Biggar(Director)

Co-investorsECEcoR1 CapitalSASamsara BioCapitalREREDMILERTRTW Investments L.P.WIWilliam Blair

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

AAAndrew Anzalone(Founder)inDLDavid Liu(Co-founder)inARAllan Reine(Chief Executive Officer)inMAMohammed Asmal(Chief Medical Officer)inALAnn Lee(Chief Technical Officer)inSMSvetlana Makhni(Chief Financial Officer)in

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)NENewpath PartnersF-F-Prime CapitalOUOUP (Osage University Partners)SASamsara BioCapital+1 more

Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.

AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US

CGChris Gibson(Co-founder and Chairman of the Board)inBCBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)NKNajat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)

Co-investorsDCDCVC (Data Collective)LULux CapitalBABaillie GiffordADAdvantage Capital PartnersAIAir Street CapitalAMAmplify Partners+22 more

Revolution Medicines is a biopharmaceutical company focused on discovering and developing medicines using its proprietary Tri-Complex Platform and RAS(ON) Biology research approach.

BiotechHealthtechMedical DevicesRedwood City, US

Margaret Horn(Executive Officer)Mark A. Goldsmith(Executive Officer, Director)inJack Anders(Chief Financial Officer)Stephen M. Kelsey(President, Research and Development)Alan Sandler(Chief Development Officer)inAnthony Mancini(Chief Global Commercialization Officer)

Co-investorsBABain Capital Life SciencesFOForesite CapitalGEGen CapitalGVGV (Google Ventures)ILIllinois VenturesNENextech Invest+2 more

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

KWKoenraad Wiedhaup(Founder & Chief Executive Officer)inRBRonald Brus(Founder & Chief Growth Officer)inJGJaap Goudsmit(Founding Scientist and Senior Advisor)inDVDinko Valerio(Founder and Chair of the Supervisory Board)inJAJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsCLClavystBioF-F-Prime CapitalGVGV (Google Ventures)BLBluebird VenturesBYByers CapitalEUEuropean Innovation Council Fund+7 more

C2i Genomics develops a whole-genome sequencing platform that uses AI algorithms to build patient-specific cancer signatures for detecting minimal residual disease (MRD) and monitoring cancer.

AI & Machine LearningBiotechDigital HealthHealthtechNew York, US

AZAsaf Zviran(Founder)inEzra Sofer(Executive Officer, Director)

BoardAPAlex Parker(Director)SRShaun Rodriguez(Director)in

Board seatECEli Casdin· per SEC Form D

Co-investorsIGiGlobe PartnersLILionBirdNANat TurnerNFNFXSESection 32

Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.

BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US

CSChristophe Schilling(Co-founder (former CEO))inBernhard Palsson(Co-founder)Carlos A. Cabrera(Executive Chairman)inJGJohn G. Gugel(Chief Executive Officer)inTMTom McDonald(SVP, Finance & Chief Financial Officer)inNBNelson Barton(SVP, Research and Development)in

Board seatECEli Casdin· per SEC Form D · $119.1M raise · filed Aug 2021

Co-investorsTHThule InvestmentsVAVantagePoint Capital PartnersVIViking GlobalDRDraper Fisher Jurvetson (DFJ)MOMohr Davidow VenturesNONovo Holdings

SomaLogic develops proteomics tools that help researchers measure protein function and study human biology across a range of scientific applications.

BiotechDeep TechHealthtechBoulder, US

LGLarry Gold(Founder)inDaniel Muehl(Executive Officer)BHByron Hewett(Executive Officer, Director)in

BoardCharles Lillis(Director)Youichi Yabuuchi(Director)Terry Randall(Director)

Board seatECEli Casdin· per SEC Form D

Co-investorsFOForesite CapitalKHKhosla VenturesMAMagnetar CapitalREReimagined VenturesSOSoleus CapitalT.T. Rowe Price

23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US

AWAnne Wojcicki(Founder)inLinda Avey(Founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)KHKathy Hibbs(Executive Officer)inPaul Cusenza(Founder)

Co-investorsADAdam NashALAllied Venture PartnersBRBright Success CapitalCICivilization Ventures Management, LlcEQEQUIAMFIFirebolt Ventures Management Company, Llc+18 more

Biopharmaceutical company discovering and developing novel biologics, protein, and peptide therapeutics.

BiotechSouth San Francisco, US

Trisha Millican(Director)James Topper(Director)Otello Stampacchia(Director)David Hirsch(Director)Volker Schellenberger(Executive Officer)James Brush(Director)

Co-investorsBABain Capital Life SciencesFRFrazier Life SciencesLOLongitude CapitalVIViking GlobalBLBlackRockFRFranklin Templeton+6 more

Apella provides real-time operating room monitoring and predictive analytics through computer vision and AI integration with EHR systems, helping surgical teams detect delays, optimize scheduling, and improve OR efficiency.

AI & Machine LearningDigital HealthHealthtech

Co-investorsK2K2 HealthVenturesLALayout VenturesOPOPAMP CAPITALTWTwine VenturesHIHighlandXOPOperator Partners+2 more

Asimov collects real-world human activity data at scale from diverse environments to create annotated datasets for training robotics AI models.

Advanced ManufacturingAI & Machine LearningData & InfrastructureRoboticsSan Francisco, US

LNLyem Ningthou(Founder)inAnshul Verma

Co-investorsY Y CombinatorAMAME Cloud VenturesANAndreessen HorowitzBIBig Wok VenturesBLBlast.ClubNTNT Capital+4 more

Asimov develops a computer-aided design platform for genetic engineering, enabling designers to program living cells by applying abstraction, standardization, and modeling to biology.

AI & Machine LearningBiotechDeep TechDeveloper ToolsBoston, US

CVChris Voigt(Founder)inANAlec Nielsen(Founder)inRSRaja Srinivas(Founder)inDDDouglas Densmore(Founder)inChristopher Voigt(Founder)Doug Densmore(Founder)

Co-investorsANAndreessen HorowitzDCDCVC (Data Collective)K5K5 GlobalKOKoch Disruptive TechnologiesPIPillar VCWIWing+2 more

Beacon Biosignals develops AI-powered EEG analytics technology to improve diagnosis and treatment of neurological, psychiatric, and sleep disorders.

AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US

Jacob A. Donoghue, M.D., Ph.D.(Executive Officer, Director)JDJacob Donoghue(CEO & Co-Founder)inJRJarrett Revels(CTO & Co-Founder)in

BoardCaitlin Donovan(Director)Pavel Raifeld(Director)NRNaveen Rao(Director)in

Co-investorsGEGeneral CatalystALAlumni VenturesCACatalio Capital Management, LPGVGV (Google Ventures)IAIaso VenturesIRIrregular Expressions+4 more

Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine.

HealthtechCambridge, US

TKTariq Kassum(Executive Officer, Director)inMBMichael Boretti(Executive Officer)inCLChristoph Lengauer(Executive Officer, Director)in

Co-investorsCACatalio Capital Management, LPFAFast Track InitiativeGVGV (Google Ventures)ALAlexandriaAMAmplitude Venture CapitalTHThird Rock Ventures

nChroma Bio is a genetic medicines company developing in vivo therapies that pair genetic cargoes with targeted delivery technologies.

BiotechLongevityBoston, US

Angelo Lombardo(Founder)David R. Liu(Founder)J. Keith Joung(Founder)Jonathan S. Weissman(Founder)Luigi Naldini(Founder)Luke Gilbert(Founder)

Co-investorsOUOUP (Osage University Partners)WEWellington ManagementATAtlas VentureGVGV (Google Ventures)NENewpath Partners

City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.

BiotechMedical DevicesCambridge, US

MKMark Keating, MD(Co-founder)KNKotaro Nakanishi, PhD(Co-founder)YTYukihide Tomari, PhD(Co-founder)PZPhillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in

Co-investorsANAN Venture PartnersARARCH Venture PartnersSOSofinnova VenturesVIViking GlobalALAltitude Ventures Management, LlcFIFidelity Investments+5 more

BiotechCambridge, US

CAChad A. Cowan(Executive Officer, Director)inLeandro Vetcher(Executive Officer)Daniel Vasella(Director)Jim Glasheen(Executive Officer, Director)Neil White(Director)

BoardMartin Murphy(Director)

Co-investorsLILifeSci Venture PartnersBABain Capital Life SciencesVEVenrock Healthcare Capital Partners

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsBIBioBritDCDCVC (Data Collective)DCDCVC BioTETenmileALAlexandriaLULux Capital

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.

BiotechDeep TechHardwareParis, FR

TYThomas Ybert(Founder)inXGXavier Godronin

Co-investorsCACatalio Capital Management, LPCOCoatue ManagementILIllumina VenturesKUKurma PartnersM M VenturesSOSofinnova Partners

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.

AI & Machine LearningBiotechWatertown, US

EKEric Kelsic(Founder)inSSSam Sinai(Founder)inAVAdrian Veres(Founder)inGCGeorge Church(Scientific Cofounder, SAB)inTBTomas Bjorklund(Scientific Co-founder, SAB)inACAlan Crane(Founder)in

Co-investorsANAndreessen HorowitzCRCRV (Charles River Ventures)GEGENERAL INCEPTIONGVGV (Google Ventures)LULux CapitalOBObvious Ventures+2 more

EQRx was a Cambridge, MA biopharma that aimed to sell lower-priced novel drugs; it was acquired by Revolution Medicines in 2023.

Alexis Borisy(Founder)

Co-investorsANAndreessen HorowitzARArboretum VenturesARARCH Venture PartnersGVGV (Google Ventures)NENextech InvestBABain Capital+1 more

Exo Therapeutics is a small molecule drug discovery company developing therapeutics through its ExoSight platform, which targets exosites—unique binding pockets on enzymes—to address previously undruggable diseases in oncology, inflammation, and other therapeutic areas.

BiotechDeep TechMedical Devices

David Liu, PhD(Founder)ASAlan Saghatelian, PhD(Co-Founder)DLDavid LiuinASAlan Saghetelian

Co-investorsNENewpath PartnersCRCRV (Charles River Ventures)NENextech InvestRARaptor GroupSASamsara BioCapitalBIBiotechnology Value Fund+1 more

Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOakland, US

MRMartin Reese(Co-Founder, President, and CEO)inMRMartin Reese, Ph.D.(Co-Founder, President, and CEO)EFErwin Frise(Vice President of Technology and Data Science)in

Co-investorsARArtis VenturesFOForesite CapitalMIMighty Capital

Flare develops AI-driven systems to manage essential workers—such as drivers, cleaners, security guards, and domestic workers—in emerging markets, vertically integrating its technology platform, worker staffing (via subsidiary Drive-Z), and customer implementation.

AI & Machine LearningFuture of WorkHR TechTokyo, JP

KKKazuki Kamiya(CEO)SISatoru Ichihara(COO)SHShinya Hayashi(CSO)HIHidefumi Iwaki(CFO)TSTomohiro Sasaki(Executive Officer (Product Development))

Co-investorsANANOBAKACACARTA VENTURES, Inc.SPSpiral VenturesAGAgent CapitalINInvusNENextech Invest+2 more

Flare is a Shopify app that lets merchants set delivery-date rules by postcode, product, and shipping method so customers only see fulfillable dates at checkout, with automation for cut-off times, order tagging, and 3PL syncing.

E-commerceLogistics & Supply ChainRetail TechSaaSLondon, GB

DPDaniel Parekh-Hill(CEO)inAlex Hooper(CTO)in

Co-investorsENEntrepreneur FirstAGAgent CapitalBABase10 PartnersINInovia CapitalINInvusNENextech Invest+3 more

Flatiron Health combines AI-powered technology and clinical expertise with real-world oncology data to help healthcare providers and life science organizations improve cancer care and research.

AI & Machine LearningData & InfrastructureHealthtechMedical DevicesNew York, US

NTNat Turner(Founder)inZachary Weinberg(Director, Executive Officer)NHNathan Hubbard(Chief Executive Officer)inMBMichael Bierl(Chief Business Officer)inCBCal Brouilette(Chief Financial Officer)inACAllison Candido(Chief Technology Officer)in

Co-investorsBOBoxGroupCACarnrite VenturesFIFirst Round CapitalGRGreat Oaks Venture CapitalGVGV (Google Ventures)STStripes+7 more

Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesSaaSNew York, US

BLBen Liu(CEO & Co-Founder)inLZLinhao Zhang(Co-Founder)inBenjamine Liu(Founder)Kit Dobyns(Founder)Mary Rozenman(Founder)

BoardALAlfred Lin(Director)in

Co-investorsANAndreessen HorowitzSESequoia CapitalSASam AltmanSESection 32THThrive CapitalFEFelicis Ventures+11 more

Foundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases.

BiotechDigital HealthMedical DevicesBoston, US

Alexis Borisy(Founder)Eric Lander(Founder)Levi Garraway(Founder)Todd Golub(Founder)

Co-investorsGVGV (Google Ventures)KHKhosla VenturesKLKleiner PerkinsNSNSG VenturesRIRidgeback CapitalANAndreessen Horowitz+1 more

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)MAMark Angelino(Executive Officer)

BoardJRJason Rhodes(Director)inCSCatherine Stehman-Breen(Director)Anthony Quinn(Director)

Co-investorsATAtlas VentureFOForesite CapitalWEWellington ManagementDEDeerfield Management CompanyF-F-Prime CapitalFIFidelity Investments+1 more

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechSouth San Francisco, US

LALisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inEMElizabeth Moreno(Executive Officer)inMSMark Sylvester(Chief Financial Officer)inAWAndrew Warner(Vice President, Product)in

Co-investorsALAlumni VenturesAVAvestria VenturesCACanaan PartnersDRDreamers VCECEcho Health VenturesGVGV (Google Ventures)+11 more

Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications.

BiotechDeep TechHealthtechMenlo Park, US

CJColin James Bell Harvey(Director)BTBrian T. Naughton(Director)inMHMaureen Hillenmeyer(CEO & Co-Founder)in

BoardAlex Kolich(Director)

Co-investorsATATEL VenturesB3B3 HoldingNENextech InvestSOSoftBank Vision FundTHThe Column Group8V8VC+1 more

insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.

AI & Machine LearningBiotechSouth San Francisco, US

DKDaphne Koller(Founder)inDVDuane Valz(General Counsel)inMRMary Rozenman(Chief Financial Officer)in

BoardRNRobert Nelsen(Director)VPVijay Pande(Director)in

Co-investorsANAndreessen HorowitzARARCH Venture PartnersDEDeviation CapitalFOForesite CapitalGVGV (Google Ventures)HOHOF Capital+9 more

Boston, US

Jurgen Horn(Executive Officer, Director)

BoardPhilip Austin(Director)in

Co-investorsF-F-Prime CapitalGVGV (Google Ventures)ANAnterra CapitalEIEight Roads VenturesNONovo Holdings

Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

SGSean George(Executive Officer, Director)inRandal Scott(Executive Officer, Director)SGShelly Guyer(Executive Officer)inLBLee Bendekgey(Executive Officer)inGeoffrey Crouse(Director)

BoardEAEric Aguiar(Director)in

Co-investorsCICivilization Ventures Management, LlcDEDecheng CapitalFIFifty YearsMAManta Ray VenturesOBOberland CapitalPRPrefix Capital+4 more

Komodo integrates healthcare data across providers, health systems, care settings, and payers to deliver insights on disease incidence, treatment patterns, and health outcomes.

AI & Machine LearningData & InfrastructureHealthtechSan Francisco, US

WSWeb Sun(Founder)inANArif Nathoo(Founder)in

Co-investorsANAndreessen HorowitzCOCoatue ManagementFEFelicis VenturesICICONIQMCMcKesson VenturesNZNZ Growth Capital Partners+7 more

Lunit develops AI-powered cancer diagnostics and biomarker analysis tools used by hospitals and biopharmaceutical companies.

AI & Machine LearningHealthtechMedical Devices

APAnthony Paek(Founder)inAnthony Seungwook Paek(Founder)Brandon Beomseok Suh(Founder)

Co-investorsATAtinum Investment Co. Ltd.GRGroom InvestmentIMIMM Investment JapanKAKakao VenturesKTKT investment Inc.KTKT Strategic Investment Fund 4+2 more

Lyra provides mental health care services through a network of evidence-based providers, combining clinical expertise with technology to deliver accessible, quality care for employers and health plans.

Digital HealthEnterprise SoftwareHealthtechHR TechMental HealthBurlingame, US

DEDavid Ebersman(Founder)inBKBob Kocher(Co-Founder and Board Member)inDBDena Bravata(Founder)AVAlethea Varra(Vice President of Clinical Care)inJSJennifer Schulz(Chief Executive Officer)Elaine Yang(Executive Officer)in

Co-investorsADAdditionBRBreyer CapitalCOCoatue ManagementDRDragoneer Investment GroupDUDurable Capital PartnersFIFidelity Investments+10 more

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGEGenoa VenturesKUKurma PartnersSOSofinnova Partners

Mnemo Therapeutics is a Paris-based clinical-stage biotech developing cell therapies using its EnfiniT epigenetic antigen discovery platform to target tumor-specific antigens for CAR-T therapies.

Co-investorsSOSofinnova PartnersALAlexandriaREREDMILE

Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.

BiotechDeep TechNew MaterialsSan Diego, US

J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)MJMichael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)

BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)

Co-investors1111.2 CapitalDCDCVC (Data Collective)ISiSelect FundKEKeshif VenturesRIRising TideALAlexandria+2 more

A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.

Biotech

Timur Yusufzai(Founder)inAPAsit Parikh(Chief Executive Officer)in

Co-investorsLILifeSci Venture PartnersNENextech InvestTHThird Rock VenturesALAlexandriaCRCreacion VenturesGOGoldman Sachs+3 more

Multiply Labs builds robotic systems that automate biologics manufacturing for pharmaceutical companies.

Advanced ManufacturingBiotechDeep TechRoboticsSan Francisco, US

FPFred Parietti(CEO)inAMAlice Melocchi(CSO)inNJNaveen Jain(Investor)inJoe Wilson(COO)Tiffany Kuo(Head of Marketing and Operations)Zack Bright(Lead Robotics Engineer)

Co-investorsFIFifty YearsGAGarage CapitalJUJude GomilaLILingottoP1P101 VenturesSTStrange Ventures+16 more

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.

BiotechDeep TechMedical DevicesBoston, US

LGLuke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)DLDavid Liu, PhD(Founder)ALAngelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)JWJonathan Weissman, PhD

Co-investorsATAtlas VentureNENewpath Partners5A5AM VenturesARARCH Venture PartnersDCDCVC (Data Collective)F-F-Prime Capital+11 more

Nest Genomics develops genomics solutions to integrate genetic testing into routine patient care.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSNew York City, US

MSMoran Snir(Founder)inGSGuy Snir(COO)inBrian Cerceo(Lead Software Engineer)Alkis Sellis(Engineering Lead)Laura Hayward(Product)Caitlin Binder(Clinical Lead)

Co-investorsY Y CombinatorALAlumni VenturesB B Capital GroupB4B4 CapitalLILionBirdMAMaven Ventures+7 more

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies.

BiotechDeep TechHealthtechMedical DevicesMontreal, CA

MDMilad Dagher(Founder)inJMJeff Munzar(Founder)inElisha Krauss(Operations Manager)Ani Muradyan(Recruiter)

Co-investorsAMAmplitude Venture CapitalAVAvant BioFIFirst Star VenturesFRFront Row VenturesRARaptor GroupY Y Combinator+9 more

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US

SKSri Kosuri(Founder)inRHRamsey Homsany(Founder)inRobert Andrade(Executive Officer, Director, Promoter)Maurice J. Costantini(Executive Officer, Director, Promoter)

Co-investorsANAndreessen Horowitz+N+ND Capital8V8VCCACarbon SiliconCACatalio Capital Management, LPEXExplorer Investments+9 more

ONI develops the Nanoimager, an automated super-resolution imaging system.

BiotechDeep TechHardwareMedical DevicesOxford, GB

Co-investorsANAnjostARARCH Venture PartnersARArtis VenturesFUFuture Planet CapitalOXOxford Technology ManagementVEVertical Venture Partners+6 more

A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.

BiotechHealthtechMedical Devices

Co-investorsANAndreessen HorowitzARARCH Venture PartnersIGiGlobe PartnersAGAgent CapitalALAlexandriaHEHeritage Medical Systems+5 more

Precision Digital Health captures real-time patient data to enable therapeutic differentiation and support value-based care in clinical research and healthcare delivery.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSIrvine, US

Jonathan Peters Badgett(Executive Officer)Connie Ellen Pearcy(Executive Officer, Director)

BoardHugh Roome(Director)Patrick Phillips(Director)Thomas Wells(Director)

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsANAndreessen HorowitzARARCH Venture PartnersGVGV (Google Ventures)LULuma GroupSASanofi VenturesABAbingworth+11 more

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

JBJeffrey Bluestone(Founder)inJBJeff Bluestone, PhD(Founder and Scientific Advisor; co-founder and former President and CEO)QTQizhi Tang, PhD(Founder and Scientific Advisor)FRFred Ramsdell, PhD(Founder and Scientific Advisor)ARAlexander Rudensky, PhD(Founder and Scientific Advisor)Stephen Dilly, MBBS, PhD(President and Chief Executive Officer)

Co-investors8V8VCARARCH Venture PartnersFRFrazier Life SciencesGVGV (Google Ventures)JDJDRF T1D FundLALAV+6 more

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

BiotechCambridge, US

Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)

Co-investorsAIAisling CapitalARARCH Venture PartnersQUQuan CapitalALAlexandriaALAlly Bridge GroupBABain Capital+11 more

Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research.

AI & Machine LearningBiotechHealthtechMedical DevicesWatertown, US

JHJoshua H. Bilenker(Executive Officer, Director, Promoter)Jeffrey Engelman(Executive Officer, Director, Promoter)inJosh Bilenker(Founder)inJosh Bilenker Jeff Engelman(Founder)

BoardKBKristina Burow(Director)inAli Satvat(Director)

Co-investorsAIAisling CapitalARARCH Venture PartnersGVGV (Google Ventures)OROrbiMedARARC VENTURESEXExor+3 more

Vanqua Bio is a biotechnology company developing molecules intended to become medicines for neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, and related neurological conditions.

BiotechDeep TechHealthtechLongevityChicago, US

Rand Sutherland(Director)inJSJim Sullivan(CEO)inKHKevin Hunt(CSO)in

BoardJSJonathan Silverstein(Director)inBernard Davitian(Director)Uya Chuluunbaatar(Director)

Co-investorsAVAvoro Capital AdvisorsOROrbiMedOUOUP (Osage University Partners)POPontifax Venture CapitalOMOmega Funds

Ventus AI is an enterprise automation platform offering AI agents ("AI teammates") that operate inside existing systems—desktop apps, web portals, and legacy software—without API integrations to automate complex business workflows, handling MFA, CAPTCHAs, and phone calls.

AI & Machine LearningEnterprise SoftwareHealthtechCasa Grande, US

Maran Vedamanikam(CEO and Manager)Peter Qian(Co-founder & CEO)Vincent Lu(Co-founder & CTO)

Co-investorsSASamsung NextANAndreessen HorowitzWNWndrCoALAlexandriaBIBiotechnology Value FundFOFonds de solidarité FTQ+5 more

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechWaltham, US

Judith Lieberman(Co-Founder)DKDaniel Koerwer(Executive Officer)inMCMichael Crackower(Executive Officer)inZachary McNealy(Executive Officer)Marcelo Bigal, M.D., Ph.D.(President and Chief Executive Officer)

BoardJRJosh Resnick(Director)in

Co-investorsANAndreessen HorowitzGVGV (Google Ventures)RARA CapitalSOSoftBank Vision FundVEVersant VenturesALAlexandria+3 more

Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.

BiotechCambridge, US

Andrew Ashe(Executive Officer)SKSekar Kathiresan(Founder)inABAndrew Bellinger(Executive Officer)Kiran Musunuru(Founder)

BoardJohn Evans(Director)APAnthony Philippakis(Director)in

Co-investorsARARCH Venture PartnersF-F-Prime CapitalGVGV (Google Ventures)RARA CapitalVEvenBio PartnersWEWellington Management+3 more

Co-investorsLILifeforce CapitalCACanaan Partners

Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins.

AI & Machine LearningBiotechDeep TechPrinceton, US

BCBen Cravatt(Scientific Founder)PBPhil Baran(Scientific Founder)JYJin-Quan Yu(Scientific Founder)Aleksandra Rizo(President and Chief Executive Officer)in

BoardJPJohn Park(Executive Officer)JCJohn Clarke(Executive Officer, Director)in

Co-investorsARARCH Venture PartnersAVAvoro Capital AdvisorsCACardinal PartnersNENextech InvestSOSoftBank Vision FundALAlexandria+4 more

Volta develops a hardware and software platform for genomics sample preparation that automates the extraction of biological information.

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsBoston, US

UUUdayan Umapathi(Founder)inPatrick ShinMagali Soumillon(Senior Director)Will Langford(Product Engineer)Liam Masters(Software Engineer)Niranjan Vissa(Head of Software)

Co-investorsBLBlindspot Ventures Management CoMAMana VenturesRIRising TideSOSoma CapitalTHThe E14 FundY Y Combinator+6 more

BiotechSan Francisco, US

Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)

BoardSaeid Akhtari(Director)

Co-investorsDYDynamk CapitalFOFormic VenturesVIViking Global Investors